A performance evaluation of MTBDRplus version 2 for the diagnosis of multidrug-resistant tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 20, Issue 5, 2016, Pages 631-637

  Seifert, M ^a   Ajbani, K ^b   Georghiou, S B ^a   Catanzaro, D ^c   Rodrigues, C ^b   Crudu, V ^d   Victor, T C ^e   Garfein, R S ^a   Catanzaro, A ^a   Rodwell, T C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b P D HINDUJA NATIONAL HOSPITAL   (India)

^c UNIVERSITY OF ARKANSAS   (United States)

^d Microbiology and Morphology Laboratory   (Moldova)

^e STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Diagnostic; Multidrug resistance; Tuberculosis

Indexed keywords

ISONIAZID; RIFAMPICIN; BACTERIAL DNA;

ACID FAST BACTERIUM; ADULT; AGE; ARTICLE; BACTERIAL LOAD; BACTERIUM CULTURE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DOSE RESPONSE; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INTERMETHOD COMPARISON; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MTBDRPLUS VERSION 2 ASSAY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIA GROWTH INDICATOR TUBE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEX; SMEAR; SPUTUM ANALYSIS; STANDARD; CALIBRATION; COMPARATIVE STUDY; EVALUATION STUDY; GENETICS; ISOLATION AND PURIFICATION; LUNG; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MOLECULAR DIAGNOSIS; MULTIDRUG RESISTANCE; PREDICTIVE VALUE; REPRODUCIBILITY; SPUTUM; STANDARDS; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

ADULT; BACTERIAL LOAD; BACTERIOLOGICAL TECHNIQUES; CALIBRATION; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84963943837     PISSN: 10273719     EISSN: 18157920     Source Type: Journal    
DOI: 10.5588/ijtld.15.0788     Document Type: Article

References (24)

1. World Health Organization. Global tuberculosis report, 2014. WHO/HTM/TB/2014.08. Geneva, Switzerland: WHO, 2014.
2. Bwanga F, Hoffner S, Haile M, Joloba M L. Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis. BMC Infect Dis 2009; 9: 67.
3. Drobniewski F, Nikolayevskyy V, Maxeiner H, et al. Rapid diagnostics of tuberculosis and drug resistance in the industrialized world: clinical and public health benefits and barriers to implementation. BMC Med 2013; 11: 190.
4. Ahmad S, Mokaddas E. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis. Respir Med 2009; 103: 1777-1790.
5. Alcaide F, Coll P. Advances in rapid diagnosis of tuberculosis disease and anti-tuberculous drug resistance. Enferm Infec Microbiol Clin 2011; 29 (Suppl 1): 34-40.
6. World Health Organization. Molecular line-probe assays for rapid screening of patients at risk of multi-drug resistant tuberculosis. Geneva, Switzerland: WHO, 2008.
7. Crudu V, Stratan E, Romancenco E, Allerheiligen V, Hillemann A, Moraru N. First evaluation of an improved assay for molecular genetic detection of tuberculosis as well as rifampin and isoniazid resistances. J Clin Microbiol 2012; 50: 1264-1269.
8. Barnard M, Gey van Pittius N C, van Helden P D, Bosman M, Coetzee G, Warren R M. The diagnostic performance of the GenoType MTBDRplus version 2 line-probe assay is equivalent to that of the Xpert MTB/RIF assay. J Clin Microbiol 2012; 50: 3712-3716.
9. N'Guessan K, Assi J S, Ouassa T, et al. Assessment of the GenoType MTBDRplus assay for rifampin and isoniazid resistance detection on sputum samples in Cote d'Ivoire. Eur J Microbiol Immunol 2014; 4: 166-173.
10. Li X X, Jiang S W, Zhang H, et al. Clinical and radiographic predictors in diagnosing sputum smear-negative pulmonary tuberculosis in HIV-negative patients: a cross-sectional study in China. Chin Med J 2013; 126: 3662-3667.
11. Gupta RK, Lawn S D, Bekker L G, Caldwell J, Kaplan R, Wood R. Impact of human immunodeficiency virus and CD4 count on tuberculosis diagnosis: analysis of city-wide data from Cape Town, South Africa. Int J Tuberc Lung Dis 2013; 17: 1014-1022.
12. Norbis L, Miotto P, Alagna R, Cirillo D M. Tuberculosis: lights and shadows in the current diagnostic landscape. New Microbiol 2013; 36: 111-120.
13. Putri F A, Burhan E, Nawas A, et al. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia. Int J Tuberc Lung Dis 2014; 18: 564-570.
14. Drain P K, Hyle E P, Noubary F, et al. Diagnostic point-of-care tests in resource-limited settings. Lancet Infect Dis 2014; 14: 239-249.
15. Hillery N, Groessl E J, Trollip A, et al. The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosis. Trials 2014; 15: 434.
16. Catanzaro A, Rodwell T C, Catanzaro D G, et al. Performance comparison of three rapid tests for the diagnosis of drug-resistant tuberculosis. PLOS ONE 2015; 10: e0136861.
17. World Health Organization. Laboratory services in tuberculosis control: microscopy Part II. Geneva, Switzerland: WHO, 1998.
18. World Health Organization. Updated interim critical concentrations for first-line and second-line DST. Geneva, Switzerland: WHO, 2012. http://www.stoptb.org/wg/gli/assets/documents/Updated%20critical%20concentration%20table- 1st%20and%202nd%20line%20drugs.pdf Accessed February 2016.
19. Newcombe R G. Improved confidence intervals for the difference between binomial proportions based on paired data. Stat Med 1998; 17: 2635-2650.
20. Luetkemeyer AF, Kendall M A, Wu X, et al. Evaluation of two line-probe assays for rapid detection of Mycobacterium tuberculosis, tuberculosis (TB) drug resistance, and non-TB Mycobacteria in HIV-infected individuals with suspected TB. J Clin Microbiol 2014; 52: 1052-1059.
21. Tukvadze N, Kempker R R, Kalandadze I, et al. Use of a molecular diagnostic test in AFB smear-positive tuberculosis suspects greatly reduces time to detection of multidrug-resistant tuberculosis. PLOS ONE 2012; 7: e31563.
22. Dorman S E, Chihota V N, Lewis J J, et al. GenoType MTBDRplus for direct detection of Mycobacterium tuberculosis and drug resistance in strains from gold miners in South Africa. J Clin Microbiol 2012; 50: 1189-1194.
23. w MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 2014; (1): CD009593.
24. Ling D I, Zwerling A A, Pai M. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur Respir J 2008; 32: 1165-1174.